In re Caremark International Inc. Derivative Litigation is the 1996 Delaware Court of Chancery decision that requires corporate boards to make a good-faith effort to monitor their company’s compliance with the law, and it exposes directors to personal liability when they fail to do so. Chancellor William T. Allen’s opinion established that passive directors can no longer point to their own ignorance as a defense: the duty to be informed is affirmative, and completely abandoning it is bad faith. Nearly three decades later, the case still defines how boards think about oversight, and a string of recent Delaware rulings has made its threat far more real.
The Scandal Behind the Case
Caremark International was a health care company that paid doctors in exchange for patient referrals, violating the Medicare and Medicaid Anti-Kickback Statute, which prohibits offering anything of value to induce referrals for services covered by federal health care programs.1Office of Inspector General. Physician Education – Fraud and Abuse Laws The company pleaded guilty to a single felony count of mail fraud. Between civil and criminal fines plus reimbursements, the total cost reached roughly $250 million.2Justia. In re Caremark Intern, Inc. Derivative Litigation
In 1994, shareholders filed a derivative lawsuit in the Delaware Court of Chancery seeking to recover those losses from the individual directors, alleging that the board had breached its fiduciary duty of care by letting employees violate federal law unchecked.2Justia. In re Caremark Intern, Inc. Derivative Litigation Chancellor Allen concluded the plaintiffs had little chance of proving a breach and approved the settlement. But the standard he articulated along the way rewrote Delaware corporate law.
The Oversight Duty Chancellor Allen Created
Before Caremark, Delaware directors could largely stay passive about employee misconduct so long as they had not personally directed it. Chancellor Allen rejected that view. He held that directors have an obligation to make a good-faith effort to ensure that an adequate corporate information and reporting system exists, and that failing to do so can make a director liable for losses caused by legal violations inside the company.2Justia. In re Caremark Intern, Inc. Derivative Litigation
The threshold he set is intentionally high. Ordinary mistakes, poor judgment, and even negligent oversight do not qualify. Only a “sustained or systematic failure of the board to exercise oversight” — the kind of wholesale abdication where directors make no real attempt to stay informed — establishes the bad faith needed for personal liability.2Justia. In re Caremark Intern, Inc. Derivative Litigation Allen was candid about the reason: if directors faced personal liability every time an employee broke the law, no one qualified would agree to serve on a board.
How Stone v. Ritter Refined the Framework
A decade later, the Delaware Supreme Court sharpened Caremark in Stone v. Ritter (2006), setting out two distinct paths for proving director oversight liability. The first is failure to implement: the board never put any reporting or information system in place. The second is failure to monitor: a system existed, but the directors consciously disregarded it, blinding themselves to problems they should have addressed. Either way, a plaintiff must show the directors knew they were not meeting their fiduciary obligations.3Justia. Stone v. Ritter – Delaware Supreme Court Decisions
Stone v. Ritter also resolved an important doctrinal question. Oversight liability falls under the duty of loyalty, not the duty of care, because proving an oversight failure requires a showing of bad faith.3Justia. Stone v. Ritter – Delaware Supreme Court Decisions That classification carries enormous practical weight.
Why Loyalty Classification Matters
Delaware corporations almost universally include a provision in their charter, authorized by Section 102(b)(7) of the Delaware General Corporation Law, that shields directors from personal liability for breaching the duty of care. The statute explicitly carves out several categories the shield does not reach: breaches of the duty of loyalty, acts not in good faith, intentional misconduct, knowing violations of law, and transactions where a director derived an improper personal benefit.4Delaware Code Online. Delaware Code Title 8 Chapter 1 – General Corporation Law
Because oversight failures sit under loyalty, a director who loses a Caremark claim cannot hide behind an exculpation clause. If a court finds bad faith, the director faces personal financial exposure for the full amount of the company’s losses. In Caremark itself, that figure was $250 million. The finding also cuts against indemnification and typical D&O insurance, both of which usually exclude bad-faith conduct, leaving little between the director and the judgment.
Marchand v. Barnhill: The Case That Gave Caremark Real Force
For years after Stone v. Ritter, Caremark claims had a reputation as almost impossible to win. Courts routinely dismissed them at the pleading stage, and the conventional view was that oversight liability existed on paper but not in practice. That changed in 2019 when the Delaware Supreme Court decided Marchand v. Barnhill.
The case grew out of a deadly listeria contamination outbreak at Blue Bell Creameries. Shareholders alleged that the board had failed to monitor food safety, the single most critical compliance risk for a company that makes food. The Delaware Supreme Court agreed the complaint stated a viable Caremark claim, pointing to three striking gaps. No board committee was charged with overseeing food safety. The full board had no regular process for discussing it. There was no expectation that management would deliver food safety reports to the board on any consistent basis. Together, those facts supported a fair inference that no board-level monitoring or reporting system for food safety existed at all.5Justia. Marchand v. Barnhill, et al.
Marchand established a principle that now drives compliance practice in regulated industries: the board must make a good-faith effort to build a reasonable system for monitoring the corporation’s “central compliance risks.” For Blue Bell, food safety was obviously that risk. A board that ignores the compliance problem most likely to destroy the company cannot claim good faith, even if it attends to other areas.5Justia. Marchand v. Barnhill, et al.
Boeing and the Red-Flag Prong
The 2021 Boeing 737 MAX derivative litigation showed that the second prong of Caremark, conscious disregard of red flags, could also survive dismissal. After two crashes killed 346 people, shareholders sued Boeing’s directors for failing to oversee airplane safety. The Court of Chancery found the complaint pled sufficient facts under both prongs.
No Boeing board committee was specifically tasked with airplane safety. The audit committee handled risk generally but never took it on. Safety was not a regular agenda item. Boeing’s internal safety reporting process had no link to the board at all. Management’s periodic reports focused on the business impact of safety crises rather than on safety data itself. On the red-flag prong, the court pointed to the board’s own statements confirming the directors knew they should have had structures in place to receive and consider safety information. That admission went directly to the scienter requirement.6Justia. In Re The Boeing Company Derivative Litigation
Officers Now Owe the Same Duty
Until recently, Caremark applied only to directors. In 2023, the Court of Chancery held in In re McDonald’s Corp. Stockholder Derivative Litigation that corporate officers owe the same oversight duty. The reasoning: the policies underlying director oversight liability apply just as forcefully, if not more so, to officers who sit closer to daily operations.
The officer version works a little differently in scope. A CEO carries company-wide responsibility, while other officers bear oversight obligations only within their own areas. A CFO must build monitoring for financial risks, not manufacturing safety. Even so, a sufficiently serious red flag may require any officer to speak up, whatever their department. The liability standard is the same as for directors: the officer must have consciously failed to make a good-faith effort to establish information systems, or must have consciously ignored red flags.
What Compliance Under Caremark Actually Looks Like
The evolution from Chancellor Allen’s opinion through Marchand and Boeing has made the practical requirements clearer than they once were. A board serious about its oversight obligations should assign compliance monitoring for the company’s central risks to a specific board committee, ensure that committee meets regularly and receives substantive reports from management, and establish a clear protocol requiring management to escalate significant compliance problems to the board level. The level of detail and reporting frequency remains a matter of business judgment; Caremark does not prescribe a single methodology.2Justia. In re Caremark Intern, Inc. Derivative Litigation
Courts are not looking for perfect systems. They are looking for evidence that the board tried, in good faith, to stay informed about the risks most likely to cause serious harm. A board that builds a reasonable monitoring system and actually pays attention to what it produces will almost always remain protected. A board that treats compliance as management’s problem alone, as Blue Bell and Boeing learned, is betting its personal wealth on employees never making a mistake.